Antimonopoly service appeals judgment in dispute with leading drug producers
MOSCOW, November 9 - RAPSI, Alyona Yegorova. The court will hear on November 10 a cassation appeal filed by the antimonopoly service against a court ruling excluding the Swiss-based F. HOFFMANN-La Roche Ltd. healthcare company and its Russian general distributor Roche-Moscow from the list of monopolies, the court told the Russian Legal Information Agency (RAPSI).
The Moscow Commercial Court revoked on April 29 the antimonopoly watchdogs decision to place the companies on the list of monopolies and ordered the service to exclude the companies from the list. The court judgment came into force after the appeals court upheld the ruling in July. However, the watchdog has filed a cassation appeal against the previous judicial acts.
The Federal Antimonopoly Service ordered on September 15, 2010 to put F. HOFFMANN-La Roche Ltd. and Roche-Moscow on the list of companies holding an over-35-percent share of any specific market or enjoyed a dominant position. The watchdog decided that the companies occupied a share of the Tamiflu antiviral medication market exceeding 35 percent.
The court ruled that the antimonopoly services decision was illegal and unfounded.
F. HOFFMANN-La Roche Ltd. is a global pharmaceuticals company founded in 1896. The company employs over 80,000 people in 150 countries. Roche produces pharmaceuticals for cancer, virology, rheumatology and transplantation.